CClinicalTrials.gg
CompletedNCT07151053Updated Sep 2, 2025

Duruöz Hand Index in Obstetric Brachial Plexus Palsy

An observational study in Obstetric Brachial Plexus Injury, sponsored by Istanbul University - Cerrahpasa. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-02.

Sponsored by Istanbul University - Cerrahpasa · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
21
Ages
6 Years to 18 Years
Sex
All
01

Study summary

Obstetric brachial plexus palsy (OBPP) arises from perinatal injury to the brachial plexus, resulting in varying degrees of motor and sensory impairment in the upper extremity. While existing assessment instruments primarily target unilateral limb function, they frequently overlook bimanual capabilities, which are essential for functional independence. This study aims to investigate the utility of the Duruöz Hand Index (DHI) as a reliable, valid, and practical instrument for evaluating functional limitations in individuals with OBPP. A cohort of 21 pediatric patients (aged 6-18 years) with OBPP was recruited from a tertiary university hospital in Turkey. Functional assessment included grip and pinch strength, range of motion, and upper extremity performance, measured using the Modified Mallet Classification, Brachial Plexus Outcome Measure (BPOM), Pediatric Outcomes Data Collection Instrument (PODCI), and DHI

02

Conditions studied

  • Obstetric Brachial Plexus Injury

Keywords

  • Brachial plexus
  • Duruöz Hand Index
03

In context

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 680 studies on the registry; 208 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study cohort consisted of patients who were under regular follow-up at our tertiary care hospital and met the inclusion criteria.

Inclusion criteria

  • Aged 6 to 18 years
  • All diagnosed with OBPP who were followed up at the Physical Medicine and Rehabilitation outpatient clinic of a tertiary university hospital in Turkey.

Exclusion criteria

Exclusion Criteria:

  • A history of trauma or surgery affecting the function of the affected extremity (other than OBPP)
  • The presence of systemic diseases that could impair hand function (such as polyneuropathy)
  • Cognitive impairments that could affect comprehension.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
21 participants (actual)
Patient registry
No

Groups and cohorts

  • Grup 1

    The study included twenty-one children aged 6 to 18 years, all diagnosed with OBPP, who were followed up at the Physical Medicine and Rehabilitation outpatient clinic of a tertiary university hospital in Turkey. The exclusion criteria were a history of trauma or surgery affecting the function of the affected extremity (other than OBPP), the presence of systemic diseases that could impair hand function (such as polyneuropathy), and cognitive impairments that could affect comprehension.

06

What researchers measure

Primary outcomes

  1. Validity and reliability

    The primary outcome measure was the Duruöz Hand Index (DHI), which was investigated to determine whether it can adequately capture impairments in bimanual function during daily activities and provide a comprehensive assessment of functional disability in patients with OBPP. To evaluate the validity of the DHI, its correlations with established outcome measures-including the Modified Mallet Classification, Brachial Plexus Outcome Measure (BPOM), Pediatric Outcomes Data Collection Instrument (PODCI), as well as grip and pinch strength and range of motion-were examined. Reliability was assessed through internal consistency using Cronbach's alpha.

    Time frame: At baseline

07

Study locations

1 site
  • Istanbul University- Cerrahpasa
    Istanbul, Fatih 34093, Turkey (Türkiye)
08

References and documents

Publications

  • Misirlioglu TO, Unalan H, Karamehmetoglu SS. Validation of Duruoz Hand Index in patients with tetraplegia. J Hand Ther. 2016 Jul-Sep;29(3):269-74. doi: 10.1016/j.jht.2015.10.001. Epub 2015 Oct 22. PubMed 26541579 ↗
  • Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, Revel M. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996 Jul;23(7):1167-72. PubMed 8823687 ↗
  • O'Berry P, Brown M, Phillips L, Evans SH. Obstetrical Brachial Plexus Palsy. Curr Probl Pediatr Adolesc Health Care. 2017 Jul;47(7):151-155. doi: 10.1016/j.cppeds.2017.06.003. Epub 2017 Jul 12. PubMed 28709767 ↗

Individual participant data

Plan to share: Yes — The individual participant data (IPD) collected during this study will be shared in an anonymized format. All identifying information will be removed to ensure participant confidentiality, and only de-identified datasets underlying the study results will be made available to qualified researchers upon request

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07151053
Lead sponsor
Istanbul University - Cerrahpasa
Responsible party
Bilal Kulaksiz (Physical medicine and rehabilitation specialist, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Sep 2, 2025
Start date
Mar 5, 2020
Primary completion
Apr 1, 2022
Completion
Jul 15, 2022
Last update
Sep 2, 2025

Study contacts

Tuğçe Özekli Mısırlıoğlu, Prof., PM&R
study director · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion